Guardant Health, Inc. - Common Stock (GH)

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
123,850,680
Total 13F shares
118,497,703
Share change
-759,333
Total reported value
$5,048,167,769
Put/Call ratio
164%
Price per share
$42.60
Number of holders
336
Value change
+$16,676,833
Number of buys
174
Number of sells
153

Institutional Holders of Guardant Health, Inc. - Common Stock (GH) as of Q1 2025

As of 31 Mar 2025, Guardant Health, Inc. - Common Stock (GH) was held by 336 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 118,497,703 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., Deep Track Capital, LP, Capital International Investors, BAILLIE GIFFORD & CO, CADIAN CAPITAL MANAGEMENT, LP, CITADEL ADVISORS LLC, EVENTIDE ASSET MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 336 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.